FDA Approved Medical Products for:
The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.
|Generic Name||Coagulation Factor VIIa (Recombinant)|
(Novo Nordisk, Inc.)
The FDA has approved this product to be used in this manner.
|Treatment of bleeding episodes in patients with Factor VII Deficiency. Treatment and peri-operative management of Glanzmann's thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.|
|More Information about this product||Drug Information Portal|